abagovomab 41
abciximab 29
abituzumab 31
abrilumab 20
actoxumab 26
adalimumab 15
aducanumab 17
afasevikumab 13
alacizumab_pegol 9
alemtuzumab 38
alirocumab 19
amatuximab 48
andecaliximab 32
anifrolumab 25
anrukinzumab 19
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 21
ascrinvacumab 19
atezolizumab 14
atinumab 21
avelumab 16
basiliximab 47
bavituximab 36
begelomab 38
benralizumab 32
bevacizumab_beta 22
bezlotoxumab 26
bimagrumab 21
bleselumab 27
blinatumomab 45
blosozumab 35
bococizumab 27
brazikumab 20
brentuximab_vedotin 35
briakinumab 21
brodalumab 23
brolucizumab 30
brontictuzumab 34
burosumab 27
cabiralizumab 34
camrelizumab 15
canakinumab 24
cantuzumab_ravtansin 47
carlumab 25
carotuximab 16
cergutuzumab_amunaleukin2 33
cergutuzumab_amunaleukin 33
certolizumab_pegol 27
cetiximab 44
citatuzumab_bogatox 32
cixutumumab 39
clivatuzumab_tetraxetan 28
codrituzumab 26
conatumumab 25
concizumab 21
crenezumab 20
crizanlizumab 33
crotedumab 22
dacetuzumab 23
daclizumab 21
dalotuzumab 39
dapirolizumab_pegol 26
daratumumab 16
dectrekumab 13
demcizumab 34
denosumab 8
depatuxizumab 32
depatuxizumab_mafodotin 32
dezamizumab 32
dinutuximab 40
diridavumab 30
domagrozumab 18
drozitumab 21
duligotuzumab 20
durvalumab 17
dusigitumab 33
efalizumab 37
efungumab 26
eldelumab 20
elezanumab 31
elgemtumab 10
elotuzumab 18
emactuzumab 29
emapalumab 28
emibetuzumab 26
enavatuzumab 27
enfortumab_vedotin 15
enoblituzumab 20
enokizumab 33
enoticumab 25
ensituximab 40
eptinezumab 15
erenumab 27
etaracizumab 17
etrolizumab 23
evinacumab 23
evolocumab 30
farletuzumab 3
fasinumab 27
fezakinumab 33
fibatuzumab 22
ficlatuzumab 33
firivumab 33
flanvotumab 28
fletikumab 35
foralumab 19
foravirumab 18
fremanezumab 32
fresolimumab 26
fulranumab 23
futuximab 29
galcanezumab 23
ganitumab 31
gantenerumab 16
gemetuzumab 36
gemtuzumab2 29
gemtuzumab 29
gevokizumab 33
girentuximab 29
glembatumumab 30
glembatumumab_vedotin 30
guselkumab 27
ibalizumab 37
ibritumomab 38
icrucumab 16
idarucizumab 38
ifabotuzumab 22
imalumab 15
imgatuzumab 28
inclacumab 26
indatuximab_ravtansin 32
indusatumab 29
inebilizumab 30
intetumumab 20
iodine_girentuximab 32
ipilimumab 5
iratumumab 24
isatuximab 39
itolizumab 27
ixekizumab 36
labetuzumab_govitecan 27
lambrolizumab 36
lampalizumab 28
lanadelumab 21
landogrozumab 19
laprituximab 36
lebrikizumab 37
lendalizumab 34
lenzilumab 28
lifastuzumab_vedotin 26
ligelizumab 31
lilotomab 38
lirilumab 33
lodelcizumab 26
lokivetmab 18
lorvotuzumab_mertansin 19
lucatumumab 33
lumretuzumab 29
lupartumab 20
lutikizumab 16
margetuximab 35
milatuzumab 32
mirvetuximab 42
mirvetuximab_soravtansin 42
modotuximab 48
mogamulizumab 23
monalizumab 29
motavizumab 36
moxetumomab_pasudotox 19
namilumab 29
naratuximab 40
naratuximab_emtansin 40
narnatumab 22
navicixizumab2 31
navicixizumab 35
navivumab 36
necitumumab 26
nemolizumab 35
nesvacumab 14
nivolumab 21
obiltoxaximab 23
obinutuzumab 37
ocaratuzumab 33
ofatumumab 18
olaratumab 36
olokizumab 25
omalizumab 20
onartuzumab 24
ontuxizumab 34
opicinumab 16
orticumab 15
otelixizumab 40
oxelumab 12
ozanezumab 32
pamrevlumab 13
panobacumab 20
parsatuzumab 33
pasotuxizumab 17
pateclizumab 23
patritumab 30
pembrolizumab 36
perakizumab 24
pidilizumab 17
pinatuzumab_vedotin 21
plozalizumab 23
pogalizumab 32
polatuzumab_vedotin 23
ponezumab 33
prezalumab 15
pritoxaximab 47
quilizumab 20
racotumomab 34
radretumab 18
ralpancizumab 31
ramucirumab 16
ranevetmab 29
ranibizumab 21
refanezumab 28
remtolumab 19
rilotumumab 30
rinucumab 28
risankizumab 39
rituximab 30
rivabazumab 25
robatumumab 22
roledumab 30
romosozumab 31
rontalizumab 27
rosmantuzumab 31
rozanolixizumab 22
sacituzumab 31
sacituzumab_govitecan 31
samalizumab 34
sapelizumab 30
sarilumab 18
secukinumab 21
seribantumab 19
setoxaximab 36
sifalimumab 20
siltuximab 26
simtuzumab 35
sirukumab 14
solanezumab 28
solitomab 30
stamulumab 28
suptavumab 28
suvizumab 22
tabalumab 32
tadocizumab 23
tamtuvetmab 31
tanezumab 33
tarextumab 12
tavolixizumab 21
telisotuzumab 40
teplizumab 21
tesidolumab 33
tezepelumab 30
tigatuzumab 16
tildrakizumab 29
timolumab 18
tisotumab 14
tosatoxumab 39
tositumomab 35
tralokinumab 43
trastuzumab 25
tregalizumab 24
trevogrumab 13
ublituximab 32
urelumab 26
ustekinumab 30
utomilumab 34
vadastuximab 34
vadastuximab_talirin 34
vandortuzumab_vedotin 23
vantictumab 29
vanucizumab2 22
vanucizumab 42
varlilumab 19
vatelizumab 37
vedolizumab 37
veltuzumab 25
vesencumab 15
vorsetuzumab 34
vorsetuzumab_mafodotin 34
vunakizumab 40
xentuzumab 20
zatuximab 48
